These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12238634)

  • 1. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
    Hata Y; Mabuchi H; Saito Y; Itakura H; Egusa G; Ito H; Teramoto T; Tsushima M; Tada N; Oikawa S; Yamada N; Yamashita S; Sakuma N; Sasaki J;
    J Atheroscler Thromb; 2002; 9(1):1-27. PubMed ID: 12238634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP).
    Teramoto T; Kashiwagi A; Mabuchi H; J-Lap Investigators
    Curr Ther Res Clin Exp; 2005 Mar; 66(2):80-95. PubMed ID: 24672115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline for hyperlipidemia].
    Seishima M
    Rinsho Byori; 2003 Jun; 51(6):576-80. PubMed ID: 12884746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.
    Moriyama K; Takahashi E
    J Atheroscler Thromb; 2016 Sep; 23(9):1126-37. PubMed ID: 27001003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guideline for diagnosis and management of hyperlipidemia for prevention of atherosclerosis in Japan].
    Teramoto T
    Nihon Rinsho; 1999 Dec; 57(12):2651-6. PubMed ID: 10638191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines.
    Shimizu R; Torii H; Yasuda D; Hiraoka Y; Kitada N; Hashida T; Yoshimoto A; Kita T; Kume N
    J Atheroscler Thromb; 2015; 22(9):949-57. PubMed ID: 25843151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of lipid management using lifestyle modification in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.
    Takahashi E; Moriyama K; Yamakado M
    Intern Med; 2013; 52(15):1681-6. PubMed ID: 23903499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia: perspectives in diagnosis and treatment.
    Yeshurun D; Gotto AM
    South Med J; 1995 Apr; 88(4):379-91. PubMed ID: 7716588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present Execution of and Problems with Clinical Lipid Examination and Application of "the Japan Atherosclerotic Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012"].
    Igarashi M; Tanji Y; Nomura T; Yamaguchi H
    Rinsho Byori; 2014 Sep; 62(9):884-91. PubMed ID: 27526534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reference values of serum lipid].
    Seishima M; Niwa T; Maeda S
    Rinsho Byori; 2001 Nov; 49(11):1115-21. PubMed ID: 11769557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of the guideline for hyperlipidemia to primary care clinic].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():483-91. PubMed ID: 11347118
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. The experts panel.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):1-14. PubMed ID: 7712390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Apr; 14(2):45-50. PubMed ID: 17485887
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T; Uno K; Miyoshi I; Khan I; Gorcyca K; Sanchez RJ; Yoshida S; Mawatari K; Masaki T; Arai H; Yamashita S
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol in the General Population.
    Kuwabara K; Harada S; Sugiyama D; Kurihara A; Kubota Y; Higashiyama A; Hirata T; Nishida Y; Kawasaki M; Takebayashi T; Okamura T
    J Atheroscler Thromb; 2016; 23(4):477-90. PubMed ID: 26961218
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.